Wedbush Starts Dendreon (DNDN) at Neutral; An Exciting Time for Prostate Cancer
Tweet Send to a Friend
Wedbush initiates coverage on Dendreon (NASDAQ: DNDN) with a Neutral. PT $39.
Wedbush analyst says, "Our thesis is based on ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Wedbush analyst says, "Our thesis is based on ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
